TrialJournal of child neurology2020

Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures.

Mark Mintz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.